三维超声造影用于评估纳米颗粒介导调控后肿瘤微血管
研究在小鼠非小细胞肺癌(A549)模型中,采用声学血管造影(AA)在血管靶向金纳米颗粒和放疗前后观察肿瘤微血管。结果发现放疗诱导血管破坏后肿瘤灌注较对照组增加,血管形态模式显示血管完整性丧失;第0天灌注差的肿瘤随时间生长减慢,提示可用治疗前微血管图减少组内治疗反应变异。
要点
- 三维声学血管造影可纵向观察肿瘤微血管灌注和血管形态变化。
- 放疗诱导血管破坏后肿瘤灌注较对照组增加,血管完整性丧失。
- 治疗前灌注差的肿瘤生长更慢,可能用于减少组内反应变异。
核心结论
- 放疗诱导血管破坏后肿瘤灌注较对照组增加,血管形态模式显示血管完整性丧失。
- 第0天灌注差的肿瘤随时间生长减慢,提示可用治疗前微血管图客观识别需剔除的动物以减少组内治疗反应变异。
研究设计与样本
- 研究类型为动物实验,使用小鼠非小细胞肺癌(A549)模型。
- 采用标准B模式和微泡增强声学血管造影(AA)在治疗前后时间点采集图像。
- 干预为血管靶向金纳米颗粒和放疗破坏肿瘤血管,并设对照组。
关键影像表现/征象
- 放疗诱导血管破坏后肿瘤灌注较对照组增加。
- 血管形态模式显示血管完整性丧失。
诊断标准与关键数值
- 建立了新指标「50%血管穿透深度」以表征微血管网络的三维空间异质性。
- 第0天灌注差的肿瘤随时间生长减慢。
临床应用与阅片要点
- 作者提示可用治疗前微血管图客观识别需剔除的动物以减少组内治疗反应变异。
- 声学血管造影联合50%血管穿透深度指标可能用于评估肿瘤微血管的空间异质性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A cost-effective method for serial in vivo imaging of tumor microvasculature has been developed. We evaluated acoustic angiography (AA) for visualizing and assessing non-small cell lung tumor (A549) microvasculature in mice before and after tumor vascular disruption by vascular-targeted gold nanoparticles and radiotherapy. Standard B-mode and microbubble-enhanced AA images were acquired at pre- and post-treatment time points. Using these modes, a new metric, 50% vessel penetration depth, was developed to characterize the 3-D spatial heterogeneity of microvascular networks. We observed an increase in tumor perfusion after radiation-induced vascular disruption, relative to control animals. This was also visualized in vessel morphology mode, which revealed a loss in vessel integrity. We found that tumors with poorly perfused vasculature at day 0 exhibited a reduced growth rate over time. This suggested a new method to reduce in-group treatment response variability using pre-treatment microvessel maps to objectively identify animals for study removal.
引用
- Kwon J, Rajamahendiran RM, Virani NA, et al. Use of 3-D Contrast-Enhanced Ultrasound to Evaluate Tumor Microvasculature After Nanoparticle-Mediated Modulation. Ultrasound Med Biol. 2019. PMID: 31694771. doi:10.1016/j.ultrasmedbio.2019.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。